General Information of Drug Off-Target (DOT) (ID: OT5133XY)

DOT Name Cell division cycle 7-related protein kinase (CDC7)
Synonyms CDC7-related kinase; HsCdc7; huCdc7; EC 2.7.11.1
Gene Name CDC7
UniProt ID
CDC7_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
4F99; 4F9A; 4F9B; 4F9C; 5UWQ; 5UWR; 6YA6; 6YA7; 6YA8
EC Number
2.7.11.1
Pfam ID
PF00069
Sequence
MEASLGIQMDEPMAFSPQRDRFQAEGSLKKNEQNFKLAGVKKDIEKLYEAVPQLSNVFKI
EDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGV
KYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKP
SNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKSHIITGNKIPLSG
PVPKELDQQSTTKASVKRPYTNAQIQIKQGKDGKEGSVGLSVQRSVFGERNFNIHSSISH
ESPAVKLMKQSKTVDVLSRKLATKKKAISTKVMNSAVMRKTASSCPASLTCDCYATDKVC
SICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD
LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQ
GHASHQPAISEKTDHKASCLVQTPPGQYSGNSFKKGDSNSCEHCFDEYNTNLEGWNEVPD
EAYDLLDKLLDLNPASRITAEEALLHPFFKDMSL
Function Kinase involved in initiation of DNA replication. Phosphorylates critical substrates that regulate the G1/S phase transition and initiation of DNA replication, such as MCM proteins and CLASPIN.
KEGG Pathway
Cell cycle (hsa04110 )
Reactome Pathway
Activation of the pre-replicative complex (R-HSA-68962 )
Transcriptional Regulation by E2F6 (R-HSA-8953750 )
Activation of ATR in response to replication stress (R-HSA-176187 )

Molecular Interaction Atlas (MIA) of This DOT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the methylation of Cell division cycle 7-related protein kinase (CDC7). [1]
TAK-243 DM4GKV2 Phase 1 TAK-243 increases the sumoylation of Cell division cycle 7-related protein kinase (CDC7). [14]
------------------------------------------------------------------------------------
25 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Cell division cycle 7-related protein kinase (CDC7). [2]
Tretinoin DM49DUI Approved Tretinoin decreases the expression of Cell division cycle 7-related protein kinase (CDC7). [3]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Cell division cycle 7-related protein kinase (CDC7). [4]
Cisplatin DMRHGI9 Approved Cisplatin increases the expression of Cell division cycle 7-related protein kinase (CDC7). [5]
Quercetin DM3NC4M Approved Quercetin decreases the expression of Cell division cycle 7-related protein kinase (CDC7). [6]
Arsenic trioxide DM61TA4 Approved Arsenic trioxide increases the expression of Cell division cycle 7-related protein kinase (CDC7). [7]
Hydrogen peroxide DM1NG5W Approved Hydrogen peroxide affects the expression of Cell division cycle 7-related protein kinase (CDC7). [8]
Carbamazepine DMZOLBI Approved Carbamazepine affects the expression of Cell division cycle 7-related protein kinase (CDC7). [9]
Troglitazone DM3VFPD Approved Troglitazone decreases the expression of Cell division cycle 7-related protein kinase (CDC7). [10]
Azathioprine DMMZSXQ Approved Azathioprine decreases the expression of Cell division cycle 7-related protein kinase (CDC7). [11]
Diclofenac DMPIHLS Approved Diclofenac affects the expression of Cell division cycle 7-related protein kinase (CDC7). [9]
Dasatinib DMJV2EK Approved Dasatinib decreases the expression of Cell division cycle 7-related protein kinase (CDC7). [12]
GSK2110183 DMZHB37 Phase 2 GSK2110183 decreases the expression of Cell division cycle 7-related protein kinase (CDC7). [13]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the expression of Cell division cycle 7-related protein kinase (CDC7). [2]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 decreases the expression of Cell division cycle 7-related protein kinase (CDC7). [15]
THAPSIGARGIN DMDMQIE Preclinical THAPSIGARGIN decreases the expression of Cell division cycle 7-related protein kinase (CDC7). [16]
Celastrol DMWQIJX Preclinical Celastrol decreases the expression of Cell division cycle 7-related protein kinase (CDC7). [17]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of Cell division cycle 7-related protein kinase (CDC7). [18]
Trichostatin A DM9C8NX Investigative Trichostatin A decreases the expression of Cell division cycle 7-related protein kinase (CDC7). [19]
Coumestrol DM40TBU Investigative Coumestrol increases the expression of Cell division cycle 7-related protein kinase (CDC7). [20]
3R14S-OCHRATOXIN A DM2KEW6 Investigative 3R14S-OCHRATOXIN A decreases the expression of Cell division cycle 7-related protein kinase (CDC7). [21]
Glyphosate DM0AFY7 Investigative Glyphosate decreases the expression of Cell division cycle 7-related protein kinase (CDC7). [22]
geraniol DMS3CBD Investigative geraniol decreases the expression of Cell division cycle 7-related protein kinase (CDC7). [23]
Lithium chloride DMHYLQ2 Investigative Lithium chloride decreases the expression of Cell division cycle 7-related protein kinase (CDC7). [24]
OXYQUINOLINE DMZVS9Y Investigative OXYQUINOLINE decreases the expression of Cell division cycle 7-related protein kinase (CDC7). [25]
------------------------------------------------------------------------------------
⏷ Show the Full List of 25 Drug(s)

References

1 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
2 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
3 Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol Sci. 2011 Dec;124(2):370-7.
4 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
5 Low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells. Biomark Insights. 2016 Aug 24;11:113-21.
6 Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clin Diagn Lab Immunol. 2004 Jan;11(1):63-9. doi: 10.1128/cdli.11.1.63-69.2004.
7 Arsenic trioxide induces different gene expression profiles of genes related to growth and apoptosis in glioma cells dependent on the p53 status. Mol Biol Rep. 2008 Sep;35(3):421-9.
8 Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses. PLoS One. 2010 Dec 17;5(12):e14352. doi: 10.1371/journal.pone.0014352.
9 Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNF-mediated hepatotoxicity. Toxicol Sci. 2014 Jul;140(1):144-59. doi: 10.1093/toxsci/kfu072. Epub 2014 Apr 20.
10 Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells. World J Gastroenterol. 2009 Jan 21;15(3):310-20.
11 A transcriptomics-based in vitro assay for predicting chemical genotoxicity in vivo. Carcinogenesis. 2012 Jul;33(7):1421-9.
12 Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts. Mol Cancer. 2010 Jun 27;9:168.
13 Novel ATP-competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells. Cancer Med. 2017 Nov;6(11):2646-2659. doi: 10.1002/cam4.1179. Epub 2017 Sep 27.
14 Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies. J Biol Chem. 2019 Oct 18;294(42):15218-15234. doi: 10.1074/jbc.RA119.009147. Epub 2019 Jul 8.
15 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
16 Endoplasmic reticulum stress impairs insulin signaling through mitochondrial damage in SH-SY5Y cells. Neurosignals. 2012;20(4):265-80.
17 Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. Cancer Cell. 2006 Oct;10(4):321-30.
18 Bisphenol A induces DSB-ATM-p53 signaling leading to cell cycle arrest, senescence, autophagy, stress response, and estrogen release in human fetal lung fibroblasts. Arch Toxicol. 2018 Apr;92(4):1453-1469.
19 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
20 Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food Chem Toxicol. 2009 Apr;47(4):787-95.
21 Molecular signatures of cytotoxic effects in human embryonic kidney 293?cells treated with single and mixture of ochratoxin A and citrinin. Food Chem Toxicol. 2019 Jan;123:374-384. doi: 10.1016/j.fct.2018.11.015. Epub 2018 Nov 11.
22 Glyphosate-based herbicides at low doses affect canonical pathways in estrogen positive and negative breast cancer cell lines. PLoS One. 2019 Jul 11;14(7):e0219610. doi: 10.1371/journal.pone.0219610. eCollection 2019.
23 Geraniol suppresses prostate cancer growth through down-regulation of E2F8. Cancer Med. 2016 Oct;5(10):2899-2908.
24 Effects of lithium and valproic acid on gene expression and phenotypic markers in an NT2 neurosphere model of neural development. PLoS One. 2013;8(3):e58822.
25 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.